Nusinersen is the sodium salt of an 18-mer 2’-O-methyl-phosphorothioate oligoribonucleotide dissolved in sodium dihydrogen phosphate dihydrate, disodium phosphate, sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium hydroxide, hydrochloric acid, and water (Spinraza™). The full sequence of the ASO is 3’-mU-mC-A-mC-mU-mU-mU-mC-A-mU-A-A-mU-G-mC-mU-G-G-5′, while the molecular mass equals 7110 g/mol.
Mobile phases were prepared using high purity solvents such as methanol, 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), as well as
N,
N-dimethylbutylamine (DMBA),
N,
N-diisopropylethylamine (DIPEA), dipropylamine (DPA) and
LC-MS water (Merck KGaA, Darmstadt, Germany). The mixture of
phenol/chloroform/isoamyl alcohol (25:24:1) (VWR International, Gdańsk, Poland), acetonitrile,
chloroform, 10 mM ammonium acetate (pH 4.5 and 9.0),
acetic acid,
ammonia solution 25% (Sigma-Aldrich, Gillingham, Dorset, UK) was also used during sample preparation step.
Studzińska S., Mazurkiewicz-Bełdzińska M, & Buszewski B. (2022). Development of the Method for Nusinersen and Its Metabolites Identification in the Serum Samples of Children Treated with Spinraza for Spinal Muscular Atrophy. International Journal of Molecular Sciences, 23(17), 10166.